<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03173339</url>
  </required_header>
  <id_info>
    <org_study_id>HighRemiSoreThroat</org_study_id>
    <nct_id>NCT03173339</nct_id>
  </id_info>
  <brief_title>Influence of Remifentanil on Postoperative Sore Throat in Patients Undergoing General Anesthesia</brief_title>
  <official_title>Influence of Remifentanil on Postoperative Sore Throat in Patients Undergoing General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Keimyung University Dongsan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Keimyung University Dongsan Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigation is planned to compare the incidence and severity of postoperative sore
      throat according to the dose of remifentanil.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Actual">August 24, 2017</completion_date>
  <primary_completion_date type="Actual">August 24, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with sore throat</measure>
    <time_frame>At 24 hr</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with sore throat</measure>
    <time_frame>At 0, 2, 4 and 24 hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with hoarseness</measure>
    <time_frame>At 0, 2, 4 and 24 hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with cough</measure>
    <time_frame>At 0, 2, 4 and 24 hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with nausea</measure>
    <time_frame>At 0, 2, 4 and 24 hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with vomiting</measure>
    <time_frame>At 0, 2, 4 and 24 hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with additional pain medication</measure>
    <time_frame>At 0, 2, 4 and 24 hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale of postoperative pain</measure>
    <time_frame>At 0, 2, 4 and 24 hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with shivering</measure>
    <time_frame>At 0, 2, 4 and 24 hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Requirements of analgesics</measure>
    <time_frame>At 0, 2, 4 and 24 hr</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Hip Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Low remifentanil and high sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Remifentanil was administered as 0.1 mcg/kg/min. Sevoflurane was started as 0.5 MAC. Sevoflurane dose was adjusted to maintain blood pressure (20% of preoperative blood pressure) and bispectral index (40-60) by 0.2 %.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High remifentanil and low sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sevoflurane was administered as 0.5 MAC. Remifentanil was started as 0.25 mcg/kg/min. Remifentanil dose was adjusted to maintain blood pressure (20% of preoperative blood pressure) and bispectral index (40-60) by 0.05 mcg/kg/min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endotracheal intubation using laryngoscope</intervention_name>
    <description>Endotracheal intubation was done using laryngoscope for general anesthesia.</description>
    <arm_group_label>Low remifentanil and high sevoflurane</arm_group_label>
    <arm_group_label>High remifentanil and low sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High remifentanil</intervention_name>
    <description>Remifentanil was started as 0.25 mcg/kg/min. Remifentanil dose was adjusted to maintain blood pressure (20% of preoperative blood pressure) and bispectral index (40-60) by 0.05 mcg/kg/min.</description>
    <arm_group_label>High remifentanil and low sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low remifentanil</intervention_name>
    <description>Remifentanil was administered as 0.1 mcg/kg/min.</description>
    <arm_group_label>Low remifentanil and high sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High sevoflurane</intervention_name>
    <description>Sevoflurane was started as 0.5 MAC. Sevoflurane dose was adjusted to maintain blood pressure (20% of preoperative blood pressure) and bispectral index (40-60) by 0.2 %.</description>
    <arm_group_label>Low remifentanil and high sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low sevoflurane</intervention_name>
    <description>Sevoflurane was administered as 0.5 MAC.</description>
    <arm_group_label>High remifentanil and low sevoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III

          -  Patients scheduled for general anesthesia with endotracheal intubation

        Exclusion Criteria:

          -  Difficult airway

          -  Rapid sequence induction

          -  Recent sore throat

          -  Recent upper respiratory infection

          -  Asthma

          -  Chronic obstructive pulmonary disease

          -  Chronic cough

          -  Pregnancy

          -  Allergy to remifentanil

          -  Friable teeth

          -  History of head and neck surgery

          -  Multiple intubation attempts

          -  Regional anesthetic agents

          -  Gastric tube

          -  Dexamethasone
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyun-Chang Kim, MD. Ph. D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keimyung University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Keimyung University</name>
      <address>
        <city>Daegu</city>
        <state>Non-US/Canada</state>
        <zip>137-040</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2017</study_first_submitted>
  <study_first_submitted_qc>May 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2017</study_first_posted>
  <last_update_submitted>August 23, 2017</last_update_submitted>
  <last_update_submitted_qc>August 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intubation</keyword>
  <keyword>pharyngitis</keyword>
  <keyword>remifentanil</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Benzocaine</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

